![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 48 Analysis
|
|
|
Reported by Jules Levin
CROI 2015 Feb 23-26 Seattle, WA
M Thompson,1 J Lalezari,2 R Kaplan,3 Y Pinedo,4 OA Sussmann Pena,5 P Cahn,6 D Stock,7 SR Joshi,7 GJ Hanna,8 M Lataillade7
1AIDS Research Consortium of Atlanta, Atlanta, GA, USA; 2Quest Clinical Research, San Francisco, CA, USA; 3Desmond Tutu HIV Foundation, Cape Town, South Africa; 4Asociacion Civil Via Libre, Lima, Peru; 5Asistencia Cientifica de Alta Complejidad SAS, Bogota, Colombia;
6Fundacion Huesped, Buenos Aires, Argentina; 7Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA; 8Bristol-Myers Squibb, Research and Development, Princeton, NJ, USA
![CROI1.gif](../images/022715/022715-8/CROI1.gif)
![CROI2.gif](../images/022715/022715-8/CROI2.gif)
![CROI3.gif](../images/022715/022715-8/CROI3.gif)
![CROI4.gif](../images/022715/022715-8/CROI4.gif)
![CROI5.gif](../images/022715/022715-8/CROI5.gif)
![CROI6.gif](../images/022715/022715-8/CROI6.gif)
![CROI7.gif](../images/022715/022715-8/CROI7.gif)
![CROI8.gif](../images/022715/022715-8/CROI8.gif)
![CROI9.gif](../images/022715/022715-8/CROI9.gif)
![CROI10.gif](../images/022715/022715-8/CROI10.gif)
![CROI11.gif](../images/022715/022715-8/CROI11.gif)
![CROI12.gif](../images/022715/022715-8/CROI12.gif)
![CROI13.gif](../images/022715/022715-8/CROI13.gif)
![CROI14.gif](../images/022715/022715-8/CROI14.gif)
![CROI15.gif](../images/022715/022715-8/CROI15.gif)
![CROI16.gif](../images/022715/022715-8/CROI16.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|